UK Company Raising $148M to Advance CBD Drug

420Patients.com is accepting qualified medical marijuana patients and caregivers to join our network. We value every registered member and we hope to serve you in Arizona. This article brought to you by 420 community friends mmjbusinessdaily.com

British drug maker GW Pharmaceuticals plans to raise $148 million from U.S. investors to advance an epilepsy drug that uses cannabidiol (CBD). The company will sell 1.7 million American Depository Shares on the Nasdaq – where it trades under the symbol GWPH – priced at $86.83 each. The drug, called Epidiolex, contains cannabidiol oil extracted […]

UK Company Raising $148M to Advance CBD Drug is a post from: Marijuana Business Daily – Legal, Financial and Dispensary News

Leave a Reply

Skip to toolbar